Home / People / Xiao Xiao
Portrait of Xiao Xiao

Xiao Xiao

Associate

CMS China
Shanghai Representative Office
3108 Plaza 66 Tower 2
1266 Nanjing Road West
Shanghai 200040
China
Languages English, Chinese, French

Xiao Xiao is Associate at CMS, China Shanghai Office. Her main practice areas include corporate law and commercial law. She has more than 4 years’ experience in advising international companies on various commercial contracts issues and general corporate issues.

Before joining CMS, China, she worked in the corporate and commercial team of another international law firm.

more less

Education

  • 2013 – Master Degree from University Vincennes-Saint Denis Paris 8, France
  • 2010 – Bachelor Degree of Law from University of Jilin (China), Law School
  • 2009 – Passed PRC Bar Exam
more less

Feed

Show only
6/5/20220
High­lights on the Re­vised Drug Re­gis­tra­tion Ad­min­is­trat­ive Meas­ures
The re­vised Drug Re­gis­tra­tion Ad­min­is­trat­ive Meas­ures (the “Re­vised Meas­ures”) pro­mul­gated by the State Ad­min­is­trat­ive for Mar­ket Reg­u­la­tion (the “SAMR”) of the People’s Re­pub­lic of China (the...
04 June 2020
High­lights on the Re­vised Drug Re­gis­tra­tion Ad­min­is­trat­ive Meas­ures
The re­vised Drug Re­gis­tra­tion Ad­min­is­trat­ive Meas­ures (the “Re­vised Meas­ures”) pro­mul­gated by the State Ad­min­is­trat­ive for Mar­ket Reg­u­la­tion (the “SAMR”) of the People’s Re­pub­lic of China (the...
6/4/2020
High­lights on the Re­vised Drug Re­gis­tra­tion Ad­min­is­trat­ive Meas­ures
The re­vised Drug Re­gis­tra­tion Ad­min­is­trat­ive Meas­ures (the “Re­vised Meas­ures”) pro­mul­gated by the State Ad­min­is­trat­ive for Mar­ket Reg­u­la­tion (the “SAMR”) of the People’s Re­pub­lic of China (the...
10 October 2019
Re­vised Drug Ad­min­is­tra­tion Law
On 26 Au­gust 2019, the Stand­ing Com­mit­tee of the Na­tion­al People’s Con­gress of the People’s Re­pub­lic of China (the “PRC”) pro­mul­gated the re­vised PRC Drug Ad­min­is­tra­tion Law (the “Re­vised Drug...
09 October 2019
Re­vised Drug Ad­min­is­tra­tion Law
On 26 Au­gust 2019, the Stand­ing Com­mit­tee of the Na­tion­al People’s Con­gress of the People’s Re­pub­lic of China (the “PRC”) pro­mul­gated the re­vised PRC Drug Ad­min­is­tra­tion Law (the “Re­vised...
10 September 2019
Vac­cines Ad­min­is­tra­tion Law in China
On 29 June 2019, the Stand­ing Com­mit­tee of the Na­tion­al People’s Con­gress of the People’s Re­pub­lic of China (the “PRC”) pro­mul­gated the PRC Vac­cines Ad­min­is­tra­tion Law (the “Vac­cines Ad­min­is­tra­tion...
09 September 2019
Vac­cines Ad­min­is­tra­tion Law in China
On 29 June 2019, the Stand­ing Com­mit­tee of the  Na­tion­al People’s Con­gress of the People’s Re­pub­lic of China (the “PRC”) pro­mul­gated the PRC Vac­cines Ad­min­is­tra­tion Law (the “Vac­cines Ad­min­is­tra­tion...
13 August 2019
Ex­ten­sion of Pi­lot Re­gime of Med­ic­al Device Hold­er
The Na­tion­al Med­ic­al Products Ad­min­is­tra­tion (the “NMPA”) pro­mul­gated the No­tice of Na­tion­al Med­ic­al Products Ad­min­is­tra­tion re­gard­ing the Ex­ten­sion of Pi­lot Re­gime of Med­ic­al Device Hold­er on Au­gust...
09/08/2019
Ex­ten­sion of Pi­lot Re­gime of Med­ic­al Device Hold­er
The Na­tion­al Med­ic­al Products Ad­min­is­tra­tion (the “NMPA”) pro­mul­gated the No­tice of Na­tion­al Med­ic­al Products Ad­min­is­tra­tion re­gard­ing the Ex­ten­sion of Pi­lot Re­gime of Med­ic­al Device Hold­er on Au­gust...
30 May 2019
No­ti­fic­a­tion with re­gard to the fol­low-up works of the can­cel­la­tions of...
The De­cision of the State Coun­cil on the Can­cela­tion and Del­eg­a­tion of a Batch of Ad­min­is­trat­ive Li­cens­ing Items pro­mul­gated by the State Coun­cil on 27 Feb­ru­ary 2019 (“De­cision Guo Fa [2019] No. 6”)...
29 May 2019
No­ti­fic­a­tion with re­gard to the fol­low-up works of the can­cel­la­tions of...
The De­cision of the State Coun­cil on the Can­cela­tion and Del­eg­a­tion of a Batch of Ad­min­is­trat­ive Li­cens­ing Items pro­mul­gated by the State Coun­cil on 27 Feb­ru­ary 2019 (“De­cision Guo Fa [2019] No. 6”)...
19 February 2019
Over­seas In­spec­tion of Drugs and Med­ic­al Devices
On 26 Decem­ber 2018, the Na­tion­al Med­ic­al Products Ad­min­is­tra­tion (“NMPA”) is­sued the Ad­min­is­trat­ive Meas­ures for Over­seas In­spec­tion Drugs and Med­ic­al Devices (“Meas­ures”) ef­fect­ive as of 26...